Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000666

Drug Information
NamePiperazine
SynonymsNCIOpen2_005575; D00807; NCIOpen2_001151; NCIOpen2_005182; NCIOpen2_005200; PZE; 1,4-Diethylenediamine; 1,4-Diazacyclohexane; Diethylenediamine; LTBB000432; Anthalazine; EINECS 203-808-3; 1951-97-9 (unspecified phosphate); P45907_SIAL; NCIOpen2_004982; NCIOpen2_004862; UN2579; Piperazin [German]; ARONIS23910; Worm-A-Ton; Spectrum_001113; Pyrazine, hexahy; 110-85-0; P0447; Wurmirazin; NCIOpen2_004952; NCIOpen2_005108; 80621_FLUKA; BIDD:GT0273; NCIOpen2_004914; IDI1_000038; NCIOpen2_004904; NCIOpen2_004874; Spectrum5_001817; Hexahydropyrazine; NCIOpen2_001231; NCIOpen2_005980; CCRIS 5950; NCIOpen2_001033; 8017-90-1; KBio2_006729; HMS2092A03; Vermex; Dispermine; NCIOpen2_004834; 16832-43-2 (unspecified hydrate); Pyrazine, hexahydro-; NCIOpen2_000984; Lumbrical; CHEBI:28568; NCIOpen2_005145; nchembio814-comp12; NINDS_000038; DivK1c_000038; NCIOpen2_001073; C07973; HSDB 1093; KBio2_001593; NCIOpen2_000988; InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H; Piperazine anhydrous; NCIOpen2_004830; Pipersol; 5-23-01-00030 (Beilstein Handbook Reference); Piperazine, anhydrous; Jsp000824; Eraverm; KBioSS_001593; NSC 474; Piperazin [Germany]; 14538-56-8 (phosphate[1:1]); P0446; NCIOpen2_004954; AR-1L1009; 854880-15-2; NCIOpen2_005072; AC1Q1IA7; NCGC00094762-02; Piperazine [UN2579] [Corrosive]; Piperazine [USAN]; BRN 0102555; DB00592; Pyrazine hexahydride; KBio2_004161; NCIOpen2_005034; Piperazine Hexa-Hydrate; 142-63-2 (hexahydrate); 1,4-Diazacyclohexane; UNII-1RTM4PAL0V; NCIOpen2_004994; KBio1_000038; Asca-Trol No. 3; 8057-14-5 (unspecified salt); NCIOpen2_001269; NCIOpen2_001111; Worm-away; NCIOpen2_001262; HMS500B20; Vermizine (TN); Eraverm (VAN); PIPERAZINE (HEXAHYDRATE); CID4837; NCIOpen2_005102; Piperazine [UN2579] [Corrosive]; 8027-81-4; MolPort-000-872-010; AKOS000269028; dro-; piperazinium oleate; LS-517; NCIOpen2_005187; SPECTRUM1500490; NCIOpen2_005062; NCIOpen2_001031; 1,4-Piperazine; Uvilon; NCIOpen2_001024; AC1Q1IA9; piperazine; AC1L1J2E; NCGC00094762-01; NCIOpen2_004942; Upixon; 7542-23-6 (mono-hydrochloride); Piperazine Dihydrochloride Dihydrochloride Hydrate; NCIOpen2_005022; 6094-40-2 (unspecified hydrochloride); AB1003720; I14-11172; Hexahydro-1,4-diazine; NCIOpen2_001071; HMS1920H20; 3597-26-0 (unspecified sulfate); NCIOpen2_004910; WLN: T6M DMTJ; 142-64-3 (di-hydrochloride); Piperazidine; NCIOpen2_005032; AC1Q1IA8; CHEMBL1412; Diethylenediamine; Antiren; NCIOpen2_005185; Diethyleneimine; Vermizine; NCIOpen2_004992; NCIOpen2_009422; Piperazin; Piperazine (USP); NSC474; 14007-05-7 (unspecified hydrobromide); 861800-35-3
IndicationAscariasis and enterobiasis
[ICD9: 127.0, 127.4   ICD10: B77, B80]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
InChIKeyGLUUGHFHXGJENI-UHFFFAOYSA-N
Canonical SMILESC1CNCCN1    
Therapeutic ClassAntinematodal Agents
CAS NumberCAS 110-85-0
FormulaC4H10N2
PubChem Compound IDCID 4837.
PubChem Substance IDSID 10174.
ChEBI28568;
SuperDrug ATC IDP02CB01
SuperDrug CAS ID000054911;
TargetGamma-aminobutyric acid receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 080671 To Reference
Ref 2Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543